Results 61 to 70 of about 636,008 (206)

Marburg Virus Disease Surveillance in the Community Through Active Case Finding in Rwanda, 2024

open access: yesInternational Journal of Infectious Diseases
Background: Marburg Virus Disease (MVD) is a high-threat pathogen with a high case fatality rate and rapid human-to-human transmission, posing serious public health risks.
Frederic Ntirenganya   +7 more
doaj   +1 more source

Proven HIV Prevention Strategies [PDF]

open access: yes, 2009
Describes strategies that, used in combination, have proven to be effective in preventing sexual, blood-borne, and mother-to-child transmission of HIV.

core  

SimpactCyan 1.0 : an open-source simulator for individual-based models in HIV epidemiology with R and Python interfaces [PDF]

open access: yes, 2019
SimpactCyan is an open-source simulator for individual-based models in HIV epidemiology. Its core algorithm is written in C++ for computational efficiency, while the R and Python interfaces aim to make the tool accessible to the fast-growing community of
Delva, Wim   +5 more
core   +2 more sources

HIV Replication Under High-Level Cabotegravir Is Associated with the Appearance of 3′-PPT Mutations, Circular DNA Transcription and Recombination

open access: yesViruses
The HIV integrase inhibitor, dolutegravir (DTG), in the absence of eliciting integrase (int) resistance, has been reported to select mutations in the virus 3′-polypurine tract (3′-PPT) adjacent to the 3′-LTR U3.
Xierong Wei   +8 more
doaj   +1 more source

Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base?

open access: yes, 2003
Many donors and countries are striving to respond to the HIV/AIDS epidemic by implementing prevention programmes. However, the resources available for providing these activities relative to needs are limited.
Walker, Damian
core   +1 more source

"Just like fever": A Qualitative Study on the Impact of Antiretroviral Provision on the Normalisation of HIV in Rural Tanzania and its Implications for Prevention. [PDF]

open access: yes, 2009
Once effective therapy for a previously untreatable condition is made available, a normalisation of the disease often occurs. As part of a broader initiative to monitor the implementation of the national antiretroviral therapy (ART) programme, this ...
Maria Roura   +74 more
core   +4 more sources

A population-based survey pooled analysis of women engaged in commercial sex in the HIV care cascade in sub-Saharan Africa, 2015–2017

open access: yesDiscover Public Health
Introduction Women who engage in commercial sex (WCS) have a higher prevalence of HIV in sub-Saharan Africa than other women of reproductive age. We aimed to describe the burden of HIV, testing, treatment, and viral load suppression (VLS) coverage among ...
Forrest Larson   +16 more
doaj   +1 more source

Alcohol use and sexual risk behaviors in the Armed Forces of the Democratic Republic of the Congo

open access: yesBMC Public Health, 2019
Background Alcohol misuse is an important contributor to sexual acquisition and transmission of HIV in military communities. This cross-sectional study quantified the prevalence of probable problematic alcohol use among male service members in the Armed ...
Bonnie Robin Tran   +5 more
doaj   +1 more source

Survey of AIDS Prevention Funders: Which Programs Are Funded, and Why?, A? [PDF]

open access: yes, 1997
This survey of foundations across the United States asked questions about the amount of money they spend on AIDS and HIV prevention, the types of prevention projects and populations their grants served, and the sources of AIDS information used by the ...
Joshua Schechtel
core  

Do Persons Living with HIV Continue to Fill Prescriptions for Antiretroviral Drugs during a Gap in Care? Analysis of a Large Commercial Claims Database

open access: yesJournal of the International Association of Providers of AIDS Care, 2017
The significance of a gap in HIV care depends, at least partially, on whether patients continue to fill prescriptions for antiretroviral (ARV) drugs during the gap in care.
Kathy K. Byrd MD, MPH   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy